Interesting Twitter thread from David Sinclair here.
Human treatments will ultimately involve isolating the active factors from young plasma and administering them as a drug, probably. Though possibly the young plasma’s benefit is that it lacks pro-aging factors that the old plasma contains. In that case, perhaps some sort of filtration or blocking agent. Stay tuned!